The Long Run with Luke Timmerman

Ep97: John Evans on Base Edited Therapeutics

Sep 7, 2021
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 4min
2
The Long Run Interview With John Evans
04:19 • 2min
3
What Was Your Next Step?
06:17 • 3min
4
Biote and the Culture
09:05 • 2min
5
Biotec Is an Apprentice Model
11:19 • 2min
6
Biatack - Your First Job?
12:52 • 3min
7
Selgine Deal - Why It Was So Important?
15:36 • 2min
8
I'm Glad I Left Agio Uround, When Was This? 20 16, 17, 20 17
17:10 • 3min
9
Embedded in a Beam?
19:44 • 2min
10
Is There a Better Mouse Trap?
21:24 • 5min
11
What's a Dman Aca?
26:04 • 3min
12
Is There Room for All Tools in the Gean Editing Landscape?
28:41 • 3min
13
Beam Is a Precision Medicine Company, and It Was Founded by David Lew and Keith Jung
31:41 • 3min
14
D and a Script - The Syntax System
34:49 • 5min
15
Genetic Medicine - What You Think About From Day One?
39:25 • 3min
16
Hematology and Hemotherapy
42:16 • 6min
17
The Importance of Gen Editing
47:48 • 2min
18
How Much Funding Have You Raised Since Ipo?
49:51 • 2min
19
The Bay Setting Approach to Therapeutics - What's Next?
52:19 • 4min
20
Canan L N P Really Deliver a Larger Mr?
56:12 • 3min
21
The Future of Biote Development and Delivery
58:57 • 2min
22
Are You Bringing This and Other Delivery Technologies Together in North Carolina?
01:00:59 • 3min
23
The Public Facedness of the Crisper and Jean Editing Conversation?
01:03:40 • 5min
24
Sickle Cell
01:08:48 • 3min